Avoid damaged skin: do not use areas that are red, swollen, bruised, scarred, tender, infected, lumpy, or numb
For instance, it healed transected muscles and counteracted NSAID toxicity without adverse effects.[24][25] Clinical Trials : A Phase I trial (NCT02637284) confirmed safety and pharmacokinetics in healthy volunteers, with no serious adverse events.[26] Phase II trials for ulcerative colitis showed encouraging results, with BPC-157 promoting remission.[27] A recent trial in inflammatory bowel disease patients reported tolerability and potential benefits.[28] The table below highlights select key studies: While robust, the reliance on animal models underscores the need for more large-scale human trials
**Decreased Pain and Improved Sleep** BPC-157 has also been shown to decrease pain and improve sleep in this study
A neutral framing is best: sublingual Epitalon may offer convenience, while injectable forms are often discussed for more direct delivery